Previous Page  86 / 96 Next Page
Information
Show Menu
Previous Page 86 / 96 Next Page
Page Background

V

ieira

RAC

et

al

.

466

R

ev

A

ssoc

M

ed

B

ras

2017; 63(5):466-475

REVIEW ARTICLE

Breast cancer screening in Brazil. Barriers related to

the health system

R

ené

A

loisio

da

C

osta

V

ieira

1,2

*, A

lessandro

F

ormenton

1,3

, S

ilvia

R

egina

B

ertolini

1,3

1

Graduate Program (Lato Sensu) in Health Care Management, Universidade Federal de São Paulo, São Paulo, SP, Brazil

2

Hospital de Câncer de Barretos, Fundação Pio XII, Barretos, SP, Brazil

3

Universidade Federal de São Paulo, Hospital São Paulo, São Paulo, SP, Brazil

S

ummary

Study conducted at Universidade Federal

de São Paulo, Hospital São Paulo, with

the Department of Health Economics,

São Paulo, SP, Brazil

Article received:

9/15/2016

Accepted for publication:

11/7/2016

*Correspondence:

Address: Rua Antenor Duarte

Villela, 1.331

Barretos, SP – Brazil

Postal code: 14784-400

reneacv@gmail.com http://dx.doi.org/10.1590/1806-9282.63.05.466

Objective:

Identify factors related to the health system that lead to a late diagnosis

of breast cancer in Brazil.

Method:

We performed a systematic review in the PubMed and LILACS databases

using as keywords “Breast cancer,” “system of health” and “Brazil or Brasil.” We

evaluated the content of the articles using the PRISMA methodology based on

PICTOS. The final date was 12/16/2015. We were able to identify 94 publications

in PubMed and 43 publications in LILACS. After assessing the title and summary,

and excluding 21 repeated publications, we selected 51 publications for full

evaluation. At this stage, we excluded 21 articles, with 30 publications remaining

for study.

Results:

The population coverage is low, and there are problems related to the

quality of mammography. Patients with lower income, nonwhite and less educated

are more vulnerable. We observed punctual and initial experiences in breast

cancer screening. Diagnosis and treatment flows must be improved. The inequality

in mortality reflects the differences related to screening structure and treatment.

Better results are observed in well-structured services.

Conclusion:

There are several barriers in the health system leading to advanced

stage at diagnosis and limiting the survival outcomes. The establishment of a

rapid and effective order for diagnosis and treatment, based on hierarchical flow,

are important steps to be improved in the public health context.

Keywords:

breast neoplasms/prevention and control, health systems, screening

programs, mammography, Unified Health System.

I

ntroduction

Breast cancer is a worldwide problem, with 1.7 million

new cases a year. Half of the cases are in developed countries,

but 62% of deaths occur in developing nations. Mortality

in the United States is declining, a fact attributed to early

diagnosis by mammography and to improvements in

treatment. In South America, however, incidence and

mortality are increasing.

1

Breast cancer is diagnosed in

advanced stages in countries with limited resources due

to a deficit in the ability to promote early detection, diag-

nosis and treatment. To assess the complexity of the health

system in relation to breast cancer, the Breast Health

Global Initiative (BHGI)

2

sought to categorize the orga-

nization levels of different countries in relation to breast

cancer, so that the basic level encourages breast self-exam,

the limited level refers to the availability of diagnostic

ultrasound and mammography, the increased level includes

diagnostic mammography with opportunistic breast

screening, and the maximum level refers to organized

population mammary screening.

2

In the United States, the

rate of mammography screening is high, but in countries

with budget limits there are no effective screening programs,

and in some cases access to treatment is limited.

1

Survival in developed countries is around 73%, and

57% in developing countries. In developing countries, the

incidence of breast cancer is lower, while the incidence/

mortality ratio is higher than in developing countries.

1

Due to the economic and logistical limitations in Brazil,

mammographic screening is not a widespread reality, a

fact that is reflected in the high number of patients diag-